Arabic Arabic English English French French German German
dark

Early anticoagulant treatment shown to reduce death in moderately ill COVID-19 patients

COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and is believed to contribute to progression to severe disease and death. New trial results show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

COVID precautions may result in more breast cancer deaths

Next Post

Lateral flow tests are 95% effective at detecting COVID-19 when used at the onset of symptoms

Related Posts
Total
0
Share